e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Stem cells and growth factors in lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2010 Abstract: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation
K. Borensztajn, P. Bresser, J. von der Thusen, C. van der Loos, B. van der Blink, M. den Bakker, J. Daalhuisen, A. Groot, M. Peppelenbosch, A. Spek (Amsterdam, Rotterdam, Netherlands)
Source:
Annual Congress 2010 - Stem cells and growth factors in lung injury
Session:
Stem cells and growth factors in lung injury
Session type:
Oral Presentation
Number:
214
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Borensztajn, P. Bresser, J. von der Thusen, C. van der Loos, B. van der Blink, M. den Bakker, J. Daalhuisen, A. Groot, M. Peppelenbosch, A. Spek (Amsterdam, Rotterdam, Netherlands). LSC 2010 Abstract: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation. Eur Respir J 2010; 36: Suppl. 54, 214
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Oral presentation: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010
Protease-activated receptor-2 triggers epithelial to mesenchymal transition: Potential relevance in pulmonary fibrosis
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011
The role of integrins in pulmonary fibrosis
Source: Eur Respir Rev 2008; 17: 157-162
Year: 2008
A role for vascular endothelial growth factor (VEGF) in fibrosis?
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009
Regulation of alternative macrophage activation by galectin-3; potential role in lung fibrosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
miR-146a-5p plays an essential role in the aberrant epithelial–fibroblast cross-talk in COPD
Source: Eur Respir J, 49 (5) 1602538; 10.1183/13993003.02538-2016
Year: 2017
Bioavailability of vascular endothelial growth factor (VEGF)? A role in pulmonary fibrosis?
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
LSC 2010 Abstract: Defective toll-like receptor-3 (TLR3) function promotes persistent interstitial lung disease and fibrosis in sarcoidosis
Source: Annual Congress 2010 - Sarcoidosis: genes and mechanisms
Year: 2010
Altered expression of the Smad signalling pathway: implications for COPD pathogenesis
Source: Eur Respir J 2006; 28: 533-541
Year: 2006
LSC Abstract – The role of platelet-expressed C-type lectin-like receptor-2 in regulating the severity of murine lung injury
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway
Source: Eur Respir J 2008; 31: 523-531
Year: 2008
MMP-12 activates protease activated receptor (PAR)-1, upregulates placenta growth factor and leads to pulmonary emphysema
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018
The role of epithelium-dependent fibroblast activation in pulmonary fibrosis
Source: Virtual Congress 2021 – Chinese programme 2021
Year: 2021
Fibroblast growth factor 9 (FGF9) modulates mesothelial cells plasticity to decrease differentiation and migration in vitro
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
YI01 - Follistatin-like 1: a crucial factor in lung development and a novel regulator of airway remodelling
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012
Expression of angiogenic growth factors and stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis in idiopathic pulmonary fibrosis: a lung tissue study
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008
Antifibrotic role of hepatocyte growth factor (HGF) in fibrosing interstial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 367s
Year: 2001
The epidermal growth factor receptor mediates allergic airway remodelling in the rat
Source: Eur Respir J 2008; 32: 1213-1223
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept